“We’re delighted to be a finalist in these highly competitive, prestigious awards,” said Owen Rose, a managing partner at Acteon. “We’re proud of how the pharma team excelled in 2016 – despite facing key succession challenges – and we aim to build on that success into the second half of 2017 and beyond.”
Succession and growth made 2016 a year of major transition for Acteon. Through strategic realignment, effective recruitment and bold organisational development, they turned challenge into opportunity and delivered their most successful commercial year to date.
Tori McKillen, Partner and Head of Pharma comments:“We are really excited to receive this recognition for the great work Acteon are doing in the medical education space. Being a finalist in this category is a testament to our talented people, the quality of our work, and the strength of our client relationships.”
Owen Rose, Managing Partner concludes:“Our vision is simple, but strong: we exist to help people flourish – our clients’ people and Acteon people.
“The success of Acteon’s projects depends on the experience, creativity and capability of our people. We are actively looking for talented individuals to add value to our services.”
The Communiqué Awards are an annual event that have been running for the last 20 years. Each year, a changing panel of over 100 industry experts and leaders, drawn from advocacy, agency, pharma, professional services and regulators take part in a rigorous judging process, championing the highest possible standards to identify winners that showcase the very best in healthcare communications.
*******
For more information, please contact Katie Gouskos on 01223 312227 or e-mail Katie Gouskos.
__________________________________________________